USD10
SPRY Shares
About ARS PharmaceuticalsARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
USD10
SPRY Shares
About ARS PharmaceuticalsARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Stats
TRADING WINDOW
Closed
OPENS AT
Mar 24 at 1:30 PM GMT+0
MARKET CAP
$782.88M
OPEN PRICE
Not enough data
LOW (1Y)
$6.66
HIGH (1Y)
$18.90
LOW (24H)
$7.60
HIGH (24H)
$8.48
VOLUME (24H)
$725.90K
7,258,930%
Price history
Time | Price | Change |
|---|---|---|
Today | Not enough data | Not enough data |
1 Day | $7.93 | |
1 Week | $8.87 | |
1 Month | $9.26 |